Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Survival Tree01:19

Survival Tree

88
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
88
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

200
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
200
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

154
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
154
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

250
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
250
Survival Curves01:18

Survival Curves

167
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
167
Cancer Survival Analysis01:21

Cancer Survival Analysis

357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Radiologic response assessment in patients with desmoid-type fibromatosis treated with percutaneous cryoablation.

European radiology experimental·2026
Same author

Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective Study.

Thyroid : official journal of the American Thyroid Association·2026
Same author

End-of-life care: A retrospective study comparing sarcoma and patients with carcinoma.

Tumori·2026
Same author

Adjuvant chemotherapy in stage I triple-negative breast cancer: A systematic review and meta-analysis of survival outcomes.

Cancer treatment reviews·2026
Same author

Toxicity-over-time analysis of anti-EGFR-based maintenance versus stop&go in left-sided, RAS/BRAF wild-type metastatic colorectal cancer.

Journal of the National Cancer Institute·2026
Same author

Bayesian sequential learning for prognostication in extremity soft tissue sarcoma (BayeSarc): a retrospective, multicentre cohort study.

The Lancet. Oncology·2026
Same journal

Predictor-Assisted Nonparametric Graphical Models With Multivariate Error-Prone Data.

Statistics in medicine·2026
Same journal

Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.

Statistics in medicine·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
查看所有相关文章

相关实验视频

Updated: Jul 11, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

机器学习方法与生存数据的样本大小和预测性能:一个模拟研究.

Gabriele Infante1,2, Rosalba Miceli2, Federico Ambrogi1,3

  • 1Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Statistics in medicine
|November 10, 2023
PubMed
概括
此摘要是机器生成的。

本研究引入了一个模拟框架,以评估对生存预测模型的样本大小需求. 机器学习方法,如随机生存森林和神经网络,需要仔细考虑样本大小,以获得最佳性能.

关键词:
机器学习是机器学习.预测 预测 预测 预测样本的大小 样本大小模拟模拟是指一个模拟模拟.时间到事件的时间.

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

相关实验视频

Last Updated: Jul 11, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

科学领域:

  • 生物统计学 生物统计学
  • 医疗保健中的机器学习
  • 生存分析的分析.

背景情况:

  • 机器学习 (ML) 方法在诊断和预后预测模型中越来越受欢迎,经常超过传统的回归技术.
  • 虽然Cox的比例危险模型是生存结果的标准,但ML通过捕获复杂的数据模式来提高性能.
  • 确定开发基于ML的生存预测模型的适当样本大小仍然是一个挑战,与传统的统计模型不同.

研究的目的:

  • 开发一个时间到事件模拟框架来评估生存预测模型的性能.
  • 将考克斯回归的性能与各种机器学习技术进行比较,包括随机生存森林,梯度增强和神经网络.
  • 调查不同样本大小对这些预测模型性能的影响.

主要方法:

  • 开发了一个时间到事件的模拟框架,使用来自公开数据库的对象复制.
  • 基于考克斯模型模拟的事件时间包括非线性,共变相互作用和时间变化的效应.
  • 考克斯回归的性能与不同样本大小的调整随机生存森林,梯度增强和神经网络进行了评估.

主要成果:

  • 模拟框架允许在各种条件下直接比较模型性能.
  • 在不同的样本大小中观察到Cox回归和ML技术之间的性能差异.
  • 该研究提供了对使用ML开发可靠的生存预测模型的样本大小要求的见解.

结论:

  • 开发的框架对于理解生存预测建模中的样本大小要求是有价值的.
  • 机器学习技术显示出有希望的结果,但需要仔细考虑样本大小,以获得最佳的预测性能.
  • 需要进一步的研究,为生存分析中的各种ML方法制定具体的样本大小准则.